Literature DB >> 21659620

Role of integrins in fibrosing liver diseases.

Eleonora Patsenker1, Felix Stickel.   

Abstract

Integrins and other cell adhesion molecules regulate numerous physiological and pathological mechanisms by mediating the interaction between cells and their extracellular environment. Although the significance of integrins in the evolution and progression of certain cancers is well recognized, their involvement in nonmalignant processes, such as organ fibrosis or inflammation, is only beginning to emerge. However, accumulating evidence points to an instrumental role of integrin-mediated signaling in a variety of chronic and acute noncancerous diseases, particularly of the liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659620     DOI: 10.1152/ajpgi.00050.2011

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  29 in total

Review 1.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 2.  Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.

Authors:  Matthias Bartneck; Klaudia Theresa Warzecha; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 3.  Assembly of human organs from stem cells to study liver disease.

Authors:  Kan Handa; Kentaro Matsubara; Ken Fukumitsu; Jorge Guzman-Lepe; Alicia Watson; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2013-12-12       Impact factor: 4.307

Review 4.  The Matrisome, Inflammation, and Liver Disease.

Authors:  Christine E Dolin; Gavin E Arteel
Journal:  Semin Liver Dis       Date:  2020-01-07       Impact factor: 6.115

5.  IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs.

Authors:  Hongcan Liu; Xingfei Pan; Hong Cao; Xin Shu; Haixia Sun; Jianxi Lu; Jiayin Liang; Ka Zhang; Fengqin Zhu; Gang Li; Qi Zhang
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

Review 6.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

7.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

Review 8.  Nanotechnology applications for the therapy of liver fibrosis.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Maria Luisa Bondì; Giuseppe Montalto; Melchiorre Cervello
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 9.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

10.  Lymphocyte subsets in alcoholic liver disease.

Authors:  Luís Costa Matos; Paulo Batista; Nuno Monteiro; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Armando Carvalho
Journal:  World J Hepatol       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.